Ranitidine Tablet
Product Images NDC 55111-131

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ranitidine (NDC 55111-131). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container (Container)

Ranitidine Tablets USP 75 mg oral tablets in a 60 count package by Dr. Reddy's Laboratories Limited. The blue and white label highlights the product as an acid reducer for heartburn associated with acid indigestion and sour stomach. The label provides drug facts, usage directions, inactive ingredients, and manufacturer details.*

FDA Label Image

Containercarton (Containercarton)

Packaging label for Ranitidine Tablets USP, 75 mg, regular strength oral tablets. The label shows 60 tablets (60 doses) per package, marketed by Dr. Reddy's Laboratories Limited. The front panel highlights the product as an acid reducer that prevents and relieves heartburn associated with acid indigestion and sour stomach. The label includes drug facts, warnings, directions, inactive ingredients, and contact information for questions. Barcodes and lot/expiration areas are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.